10x Genomics
TXG
TXG
288 hedge funds and large institutions have $3.88B invested in 10x Genomics in 2024 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 113 increasing their positions, 76 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.22% more ownership
Funds ownership: 96.15% → 98.37% (+2.2%)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
31% less capital invested
Capital invested by funds: $5.6B → $3.88B (-$1.72B)
Holders
288
Holding in Top 10
6
Calls
$14.3M
Puts
$3.9M
Top Buyers
| 1 | +$98.5M | |
| 2 | +$58.8M | |
| 3 | +$58.8M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$46.7M |
| 5 |
Millennium Management
New York
|
+$37.7M |
Top Sellers
| 1 | -$140M | |
| 2 | -$98.9M | |
| 3 | -$61.3M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$40.8M |
| 5 |
SIM
SRS Investment Management
New York
|
-$38.3M |